CN1795888A - 猴耳环提取物用于制备抗过敏药物、食品及化妆品的应用 - Google Patents
猴耳环提取物用于制备抗过敏药物、食品及化妆品的应用 Download PDFInfo
- Publication number
- CN1795888A CN1795888A CN 200410077659 CN200410077659A CN1795888A CN 1795888 A CN1795888 A CN 1795888A CN 200410077659 CN200410077659 CN 200410077659 CN 200410077659 A CN200410077659 A CN 200410077659A CN 1795888 A CN1795888 A CN 1795888A
- Authority
- CN
- China
- Prior art keywords
- ramulus
- folium pithecellobii
- pithecellobii lucidi
- extract
- allergic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 16
- 239000002537 cosmetic Substances 0.000 title claims abstract description 11
- 235000013305 food Nutrition 0.000 title claims abstract description 7
- 229940079593 drug Drugs 0.000 title abstract description 3
- 230000003266 anti-allergic effect Effects 0.000 title description 4
- 240000001173 Archidendron ellipticum Species 0.000 title 1
- 206010002198 Anaphylactic reaction Diseases 0.000 claims abstract description 17
- 230000036783 anaphylactic response Effects 0.000 claims abstract description 17
- 208000003455 anaphylaxis Diseases 0.000 claims abstract description 17
- 208000010668 atopic eczema Diseases 0.000 claims abstract description 14
- 206010012434 Dermatitis allergic Diseases 0.000 claims abstract description 9
- 201000008937 atopic dermatitis Diseases 0.000 claims abstract description 9
- 208000026935 allergic disease Diseases 0.000 claims abstract description 8
- 206010039085 Rhinitis allergic Diseases 0.000 claims abstract description 6
- 201000010105 allergic rhinitis Diseases 0.000 claims abstract description 6
- 206010050639 Allergic pharyngitis Diseases 0.000 claims abstract description 5
- 206010020751 Hypersensitivity Diseases 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 208000024891 symptom Diseases 0.000 claims description 13
- 208000030961 allergic reaction Diseases 0.000 claims description 12
- 230000007815 allergy Effects 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 claims description 4
- 206010048908 Seasonal allergy Diseases 0.000 claims description 4
- 230000000172 allergic effect Effects 0.000 claims description 4
- 235000013402 health food Nutrition 0.000 claims description 4
- 231100000957 no side effect Toxicity 0.000 claims description 4
- 150000001298 alcohols Chemical class 0.000 claims description 3
- 235000013373 food additive Nutrition 0.000 claims description 3
- 239000002778 food additive Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 3
- 239000000470 constituent Substances 0.000 claims description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 2
- 238000004378 air conditioning Methods 0.000 claims 1
- 239000002798 polar solvent Substances 0.000 claims 1
- 244000033373 Pithecellobium clypearia Species 0.000 abstract description 6
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 31
- 230000000694 effects Effects 0.000 description 21
- 238000002360 preparation method Methods 0.000 description 15
- 240000001307 Myosotis scorpioides Species 0.000 description 13
- 206010030113 Oedema Diseases 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 230000002052 anaphylactic effect Effects 0.000 description 9
- 239000000427 antigen Substances 0.000 description 9
- 102000036639 antigens Human genes 0.000 description 9
- 108091007433 antigens Proteins 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 8
- 206010012442 Dermatitis contact Diseases 0.000 description 7
- 235000013361 beverage Nutrition 0.000 description 7
- 208000010247 contact dermatitis Diseases 0.000 description 7
- 230000003111 delayed effect Effects 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 206010070834 Sensitisation Diseases 0.000 description 6
- 230000008313 sensitization Effects 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 230000002792 vascular Effects 0.000 description 6
- 238000011161 development Methods 0.000 description 5
- 210000002540 macrophage Anatomy 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 210000001744 T-lymphocyte Anatomy 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- -1 some antiseptic Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 108060003951 Immunoglobulin Proteins 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000001387 anti-histamine Effects 0.000 description 3
- 239000000739 antihistaminic agent Substances 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 210000003630 histaminocyte Anatomy 0.000 description 3
- 102000018358 immunoglobulin Human genes 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 238000010254 subcutaneous injection Methods 0.000 description 3
- 239000007929 subcutaneous injection Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000008728 vascular permeability Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 241000581650 Ivesia Species 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000000043 antiallergic agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940088529 claritin Drugs 0.000 description 2
- 229960003699 evans blue Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 150000002617 leukotrienes Chemical class 0.000 description 2
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- ZPLUZNXSYCCJOE-UHFFFAOYSA-N phosphoric acid;propan-2-one Chemical compound CC(C)=O.OP(O)(O)=O ZPLUZNXSYCCJOE-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 235000011888 snacks Nutrition 0.000 description 2
- 235000010378 sodium ascorbate Nutrition 0.000 description 2
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 2
- 229960005055 sodium ascorbate Drugs 0.000 description 2
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- GOCCREQJUBABAL-UHFFFAOYSA-N 2,2-dihydroxyacetic acid Chemical compound OC(O)C(O)=O GOCCREQJUBABAL-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000244188 Ascaris suum Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010011953 Decreased activity Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 208000001718 Immediate Hypersensitivity Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 241001125929 Trisopterus luscus Species 0.000 description 1
- 206010045240 Type I hypersensitivity Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000012876 acute enteritis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010216 atopic IgE responsiveness Diseases 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- 210000003912 basophilic leucocyte Anatomy 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000000222 eosinocyte Anatomy 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002955 secretory cell Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000027930 type IV hypersensitivity disease Diseases 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 动物数 | 重量(mg/8mm耳缘) |
正常小鼠(-DNFB) | 10 | 17.9±0.4 |
H2O对照组(+DNFB) | 10 | 31.8±2.1 |
猴耳环提取物50mg/kg(+DNFB) | 10 | 27.2±1.6 |
猴耳环提取物100mg/kg(+DNFB) | 10 | 23.6±0.9(p<0.05) |
猴耳环提取物200mg/kg(+DNFB) | 10 | 21.8±1.3(p<0.05) |
组别 | 动物数 | 埃文斯兰渗漏(leakage)(μg/8mm耳缘) |
正常小鼠(-DNFB) | 10 | -- |
H2O对照组(+DNFB) | 10 | 5.79±0.72 |
猴耳环提取物50mg/kg(+DNFB) | 10 | 4.48±1.02 |
猴耳环提取物100mg/kg(+DNFB) | 10 | 4.06±0.69(p<0.05) |
猴耳环提取物200mg/kg(+DNFB) | 10 | 2.68±1.40(p<0.01) |
组别 | 动物数 | 足掌浮肿(mm) |
正常小鼠(-SRBC) | 10 | 3.26±0.24 |
H2O对照组(+SRBC) | 10 | 3.62±0.21 |
猴耳环提取物50mg/kg(+SRBC) | 10 | 3.420.15(p<0.05) |
猴耳环提取物100mg/kg(+SRBC) | 10 | 3.32±0.23(p<0.01) |
猴耳环提取物200mg/kg(+SRBC) | 10 | 3.33±0.09(p<0.005) |
组别 | 动物数 | 重量(mg/8mm耳缘) |
正常小鼠(-DNFB) | 10 | 16.5±1.4 |
H2O对照组(+DNFB) | 10 | 27.4±2.9 |
猴耳环提取物50mg/kg(+DNFB) | 10 | 24.6±1.3(p<0.05) |
猴耳环提取物100mg/kg(+DNFB) | 10 | 21.2±3.9(p<0.001) |
猴耳环提取物200mg/kg(+DNFB) | 10 | 19.5±2.1(p<0.001) |
组别 | 动物数 | 埃文斯兰渗漏(leakage)(μg/8mm耳缘) |
正常小鼠(-DNFB) | 10 | -- |
H2O对照组(+DNFB) | 10 | 4.17±1.64 |
猴耳环提取物50mg/kg(+DNFB) | 10 | 3.83±1.52 |
猴耳环提取物100mg/kg(+DNFB) | 10 | 3.42±0.50 |
猴耳环提取物200mg/kg(+DNFB) | 10 | 2.94±0.32(p<0.05) |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100776593A CN100548321C (zh) | 2004-12-29 | 2004-12-29 | 猴耳环提取物用于制备抗过敏药物、食品及化妆品的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100776593A CN100548321C (zh) | 2004-12-29 | 2004-12-29 | 猴耳环提取物用于制备抗过敏药物、食品及化妆品的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1795888A true CN1795888A (zh) | 2006-07-05 |
CN100548321C CN100548321C (zh) | 2009-10-14 |
Family
ID=36817343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100776593A Expired - Fee Related CN100548321C (zh) | 2004-12-29 | 2004-12-29 | 猴耳环提取物用于制备抗过敏药物、食品及化妆品的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100548321C (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103330664A (zh) * | 2013-06-08 | 2013-10-02 | 南方医科大学 | 一种具有去屑功能的中药提取物在发用化妆品的应用 |
CN103385912A (zh) * | 2013-07-24 | 2013-11-13 | 中山大学 | 猴耳环提取物及其在制备抗耐甲氧西林金黄色葡萄球菌药物中的应用 |
CN103720957A (zh) * | 2013-12-31 | 2014-04-16 | 芜湖乐锐思信息咨询有限公司 | 用于腺样体肥大的中药配方及其制备方法 |
CN103800580A (zh) * | 2013-12-27 | 2014-05-21 | 芜湖乐锐思信息咨询有限公司 | 用于腺样体肥大的中药配方及其制备方法 |
EP2747573A4 (en) * | 2011-08-24 | 2015-04-01 | Avon Prod Inc | COMPOSITIONS FOR COLLAGEN AND ELASTIC INJURIATION AND THEIR USE |
CN104736204A (zh) * | 2012-12-11 | 2015-06-24 | 雅芳产品公司 | 通过调节wipi-1改善皮肤的老化外观的方法 |
CN104974018A (zh) * | 2015-06-15 | 2015-10-14 | 沈阳药科大学 | 从中药猴耳环中提取的化合物及其用途 |
CN105998153A (zh) * | 2016-05-10 | 2016-10-12 | 中山大学 | 猴耳环提取物在制备抗产超广谱β-内酰胺酶大肠杆菌药物中的应用 |
CN111012819A (zh) * | 2019-12-31 | 2020-04-17 | 江西杏林白马药业有限公司 | 一种猴耳环提取物纳米制剂及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1364518A (zh) * | 2001-01-17 | 2002-08-21 | 杨孟君 | 纳米猴耳环消炎制剂药物及其制备方法 |
-
2004
- 2004-12-29 CN CNB2004100776593A patent/CN100548321C/zh not_active Expired - Fee Related
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10195136B2 (en) | 2011-08-24 | 2019-02-05 | Avon Products, Inc. | Collagen and elastin stimulating compositions and uses thereof |
EP2747573A4 (en) * | 2011-08-24 | 2015-04-01 | Avon Prod Inc | COMPOSITIONS FOR COLLAGEN AND ELASTIC INJURIATION AND THEIR USE |
US9238000B2 (en) | 2012-12-11 | 2016-01-19 | Avon Products, Inc. | Method of improving aging appearance of skin by modulation of WIPI-1 |
CN104736204A (zh) * | 2012-12-11 | 2015-06-24 | 雅芳产品公司 | 通过调节wipi-1改善皮肤的老化外观的方法 |
CN103330664A (zh) * | 2013-06-08 | 2013-10-02 | 南方医科大学 | 一种具有去屑功能的中药提取物在发用化妆品的应用 |
CN103385912A (zh) * | 2013-07-24 | 2013-11-13 | 中山大学 | 猴耳环提取物及其在制备抗耐甲氧西林金黄色葡萄球菌药物中的应用 |
CN103385912B (zh) * | 2013-07-24 | 2015-06-17 | 中山大学 | 猴耳环提取物及其在制备抗耐甲氧西林金黄色葡萄球菌药物中的应用 |
CN103800580A (zh) * | 2013-12-27 | 2014-05-21 | 芜湖乐锐思信息咨询有限公司 | 用于腺样体肥大的中药配方及其制备方法 |
CN103720957A (zh) * | 2013-12-31 | 2014-04-16 | 芜湖乐锐思信息咨询有限公司 | 用于腺样体肥大的中药配方及其制备方法 |
CN104974018A (zh) * | 2015-06-15 | 2015-10-14 | 沈阳药科大学 | 从中药猴耳环中提取的化合物及其用途 |
CN105998153A (zh) * | 2016-05-10 | 2016-10-12 | 中山大学 | 猴耳环提取物在制备抗产超广谱β-内酰胺酶大肠杆菌药物中的应用 |
CN105998153B (zh) * | 2016-05-10 | 2019-09-17 | 中山大学 | 猴耳环提取物在制备抗产超广谱β-内酰胺酶大肠杆菌药物中的应用 |
CN111012819A (zh) * | 2019-12-31 | 2020-04-17 | 江西杏林白马药业有限公司 | 一种猴耳环提取物纳米制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100548321C (zh) | 2009-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20030096025A1 (en) | Antiallergic agent, anti-inflammatory agent, anti-atopic dermatitis agent and antipsoriatic agent | |
KR20150086982A (ko) | 원지 추출물을 유효성분으로 함유하는 아토피 피부염의 예방 또는 치료용 조성물 | |
WO2019132625A1 (ko) | 약초 혼합추출물을 유효성분으로 함유하는 아토피 피부염의 예방, 개선 또는 치료용 조성물 | |
KR20090084159A (ko) | 감 추출물 또는 탄닌을 유효성분으로 함유하는면역관련질환 치료용 조성물 | |
CN100548321C (zh) | 猴耳环提取物用于制备抗过敏药物、食品及化妆品的应用 | |
KR101826737B1 (ko) | 생약재 추출물을 유효성분으로 하는 근육틱 및 우울증 개선용 조성물 및 그의 제조방법 | |
KR20180041887A (ko) | 고욤잎 및 포도송이 가지의 혼합 추출물을 유효성분으로 함유하는 아토피 피부염의 예방, 개선 또는 치료용 조성물 | |
KR101270736B1 (ko) | 한방추출물을 유효성분으로 하는 소양증 개선용 조성물 | |
KR101851167B1 (ko) | 조팝나무 추출물을 유효성분으로 함유하는 알러지성 질환의 예방 및 치료용 약학적 조성물 | |
KR20090084435A (ko) | 어성초 및 느릅나무 혼합추출물을 유효 성분으로 함유하는알레르기성 피부질환 예방 및 치료용 약학적 조성물 | |
KR101160249B1 (ko) | 자라 추출물을 함유하는 피부질환의 개선 또는 치료용 약학적 조성물 | |
KR101865142B1 (ko) | 조팝나무, 배나무, 뱀무의 혼합 추출물을 유효성분으로 함유하는 알러지성 질환의 예방 및 치료용 약학적 조성물 | |
KR101732483B1 (ko) | 연교 추출물을 유효성분으로 함유하는 말초신경병증 예방, 개선 또는 치료용 조성물 | |
Yadav et al. | Experimental evidences showing nutritional and medicinal property of Carica papaya plant | |
US11484562B2 (en) | Composition for preventing or treating obesity comprising natural mixture extracts | |
KR20220082396A (ko) | 계혈등 추출물을 유효성분으로 포함하는 알러지성 질환의 예방, 개선 또는 치료용 조성물 | |
KR101049474B1 (ko) | 천마 추출물을 유효성분으로 함유하는 약물 중독 또는 정신분열증 예방 또는 치료용 약학적 조성물 | |
JP2003252786A (ja) | 抗アレルギー物質及びその製造方法,並びに抗アレルギー剤及び健康食品 | |
CN1297299C (zh) | 可可茶提取物用于制备抗过敏及炎症的药物、食品及化妆品的应用 | |
KR20200132261A (ko) | 싸리 추출물을 포함하는 근위축 예방 및 치료용 조성물 | |
CN114931214B (zh) | 一种改善听力损伤的中草药组合物及其制备方法与应用 | |
KR102382067B1 (ko) | 형개와 익지인의 복합 추출물을 유효성분으로 함유하는 아토피성 피부염 치료용 조성물 | |
KR102227261B1 (ko) | 고욤 효소처리물을 유효성분으로 함유하는 아토피 피부염의 예방, 개선 또는 치료용 조성물 | |
KR20120057161A (ko) | 거북 추출물을 함유하는 피부질환의 개선 또는 치료용 약학적 조성물 | |
CN113842405B (zh) | 构树根皮提取物在制备皮肤抗敏止痒药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20070810 Address after: Six floor, Longde building, 337 Tianhe Road, Guangzhou, China Applicant after: Laitai Pharmacy Co., Ltd., Guangzhou Address before: Guangdong, Conghua province Guangzhou economic and Technological Development Zone, No. 16 from broad road Applicant before: Guangzhou LifeTech Pharmaceutical Co., Ltd. |
|
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Wu Rongrong Document name: Notice of conformity |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGZHOU LIFETECH PHARMACEUTICALS LTD. Free format text: FORMER OWNER: GUANGZHOU LIFETECH PHARMACEUTICAL CO., LTD. Effective date: 20101020 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 510620 6/F, LONGDE BUILDING, NO.337, TIANHE ROAD, GUANGZHOU CITY TO: 510990 NO.16, GUANGCONG AVENUE, GUANGDONG CONGHUA ECONOMIC DEVELOPMENT ZONE, CONGHUA, GUANGZHOU CITY, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20101020 Address after: 510990, Guangdong, Conghua Guangdong Conghua Guangzhou Economic Development Zone, No. 16 from broad road Patentee after: Guangzhou LifeTech Pharmaceutical Co., Ltd. Address before: 510620, six building, Longde building, 337 Tianhe Road, Guangzhou Patentee before: Laitai Pharmacy Co., Ltd., Guangzhou |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091014 Termination date: 20201229 |
|
CF01 | Termination of patent right due to non-payment of annual fee |